FDA Approved: PEMFEXY — Supplemental Application (Eagle Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PEMFEXY (pemetrexed) from Eagle Pharmaceuticals, Inc. under NDA 209472.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• PEMFEXY (pemetrexed)

Snippet

SUPPL AP for PEMFEXY (PEMETREXED)